Compare
Alignment Healthcare vs Labcorp (ALHC vs LH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Alignment Healthcare (ALHC) returned -57.0% and Labcorp (LH) +46.2%; so far this year the figures are -62.8% and +46.1%.
Labcorp is the larger company by market value, about 19.3 times the size of Alignment Healthcare.
On trailing earnings, ALHC trades at 56.5 times and LH at 30.1 times.
Revenue grew +35.9% at ALHC and +6.0% at LH over the last year.
ALHC pays no dividend. LH yields 0.79%.
Data as of the latest close. Not investment advice.
Relative performance
| ALHC | LH | |
|---|---|---|
| Price | $7.34 | $366.57 |
| 1-day | -2.91% | +0.90% |
| YTD | -62.84% | +46.11% |
| 1 year | -56.98% | +46.22% |
| 3 years | +10.21% | +79.74% |
| Market cap | $1.5B | $29.8B |
| P/E | 56.5 | 30.1 |
| P/S | 0.31 | 2.04 |
| P/B | 5.54 | 3.36 |
| Revenue growth | +35.90% | +6.00% |
| EPS growth | — | +19.60% |
| Gross margin % | — | 29.0 |
| Net margin % | 0.6 | 6.9 |
| ROE % | 10.4 | 11.3 |
| Debt / equity | 1.17 | 0.66 |
| FCF yield % | 5.0 | 4.3 |
| Dividend yield % | — | 0.79 |
| Beta | 0.68 | 0.38 |
| RSI (14) | 39.3 | 69.9 |
| Technical rating |